Type and hit ENTER

My account

ProAxsis reports first NEATstik® sale

February 15, 2018
Following on from the commercialisation update provided in November, ProAxsis is pleased to report …
ProAxsis Launches ProteaseTag® Active Plasmin Immunoassay following CE Mark registration

January 8, 2018
ProAxsis Limited (www.proaxsis.com) today announces that it has successfully registered a CE Mark for …
ProAxsis abstracts at 2017 British Thoracic Society Winter Meeting

December 5, 2017
ProAxsis’ ProteaseTag® technology will again be featured at the Winter meeting of the British …

ProAxsis

RT @DrJRHurst: IMPACT #COPD results now published. We already know 2 drugs are better than 1 for exacerbation prevention, but 3 may not be…

3 days ago

RT @lunguk: Lung disease is one of the top 3 killers in the UK, and over the past 10 years, the numbers of people hasn't gotten better. We'…

7 days ago

Great to see our ProteaseTag Active NE featured in @Laboratory_talk https://t.co/dvryH2CTb3 @DiagenicsLtd… https://t.co/jIgwEZqwIn

14 days ago

RT @gunnar_ns: Few days left to apply for our exciting, #MarieSkłodowskaCurie-funded #PhD-project in #host-#pathogen interaction and tackl…

20 days ago

Copyright © 2016-2018 - ProAxsis - All rights reserved.

My account | ProAxsis